BSE demat auction listing for settlement number 789 covering securities from various companies that failed to deliver shares.
Impact
Medium
Severity
Medium
Justification
Routine demat auction affecting multiple securities due to delivery failures. Important for affected traders and brokers but part of standard settlement operations.
List of securities and quantities subject to demat auction in settlement number 789 dated January 2, 2026.
Impact
Medium
Severity
Medium
Justification
Demat auction affects multiple securities and their delivery obligations. Members with short positions in these securities must participate in the auction to fulfill delivery requirements. Medium impact as it's a routine settlement mechanism affecting specific positions.
BSE demat auction settlement number 788 listing securities available for auction due to delivery shortages.
Impact
Medium
Severity
Medium
Justification
Regular demat auction affecting multiple securities due to delivery shortages; important for clearing and settlement process but routine operational procedure
BSE demat auction settlement number 788 listing securities available for auction on January 1, 2026.
Impact
Low
Severity
Low
Justification
Routine demat auction notice listing securities and quantities available for settlement 788. This is a standard operational communication with limited market-wide impact, affecting only specific auction participants.
NSE Clearing publishes the revised list of 178+ securities eligible for transactions in the Securities Lending & Borrowing Scheme (SLBS) for January 2026.
Impact
Medium
Severity
Low
Justification
Routine monthly update of SLBS eligible securities list. Important for participants in securities lending/borrowing but represents normal operational maintenance rather than policy change.
List of securities and quantities scheduled for demat auction under settlement number 772 dated December 9, 2025.
Impact
Medium
Severity
Medium
Justification
Routine demat auction for delivery shortfalls affecting multiple securities. Important for affected scrips and their holders but limited broader market impact.